Perry Syndrome FoundationEducation · Connection · Hope

A trusted home for a rare diagnosis

Answers for today.
Hope for what’s next.

Clear, evidence-based information and a connected community for people and families living with Perry syndrome.

Evidence-linked information · Worldwide resources · Family-centered language

Rare does not have to mean invisible.

Perry syndrome—also called Perry disease—is part of the spectrum of DCTN1-related neurodegeneration. It usually begins in adulthood and progresses over time.

Changes in the DCTN1 gene affect dynactin, a protein complex involved in transport inside nerve cells. The condition is usually inherited in an autosomal dominant pattern, meaning each child of an affected person has a 50% chance of inheriting the family variant. New (de novo) variants can also occur.

49 yearsaverage age of onset
about 5 yearsaverage reported course
50%inheritance risk for each child

Figures describe published groups and cannot predict one person’s course.
GeneReviews ↗

DCTN1

Four signs clinicians look for

01

Parkinsonism

Slowness, stiffness, tremor, balance changes, or a shuffling gait. Symptoms may resemble Parkinson’s disease.

02

Breathing changes

Slower or shallow breathing—often first noticed during sleep. Symptoms may be subtle and need active monitoring.

03

Depression or apathy

Depression, loss of motivation, social withdrawal, anxiety, or other behavior and mood changes.

04

Weight loss

Unexpected and sometimes rapid weight loss, which can occur even when appetite remains good.

From suspicion to a confirmed answer

No single symptom proves Perry syndrome. Diagnosis brings the clinical pattern, family history, respiratory assessment, and genetic testing together.

  1. 1

    Recognize the pattern

    A neurologist—ideally a movement-disorders specialist—reviews movement symptoms alongside mood, weight, breathing, and family history.

  2. 2

    Assess breathing and related symptoms

    A clinician may arrange overnight oximetry or a sleep study, blood-gas testing, lung-function testing, brain imaging, and other tests to exclude more common conditions.

  3. 3

    Meet with genetics

    Genetic counseling helps a family understand what testing can and cannot tell them, inheritance, consent, and implications for relatives.

  4. 4

    Confirm with molecular testing

    A heterozygous pathogenic variant in DCTN1 can establish DCTN1-related neurodegeneration. Results should be interpreted by qualified genetics and neurology professionals.

2018 international consensus

Features in the international diagnostic criteria

AParkinsonismBApathy or depressionCRespiratory symptomsDUnexpected weight lossEFamily historyFDCTN1 test result

All four major symptoms do not need to be present early. Published criteria describe definite, probable, and possible disease and should be applied by clinicians.

Open article

Practical checklist

Preparing for an appointment

  • Write a symptom timeline
  • Bring family health history
  • List medicines and supplements
  • Note sleep or breathing changes
  • Bring prior scans and test results
  • Ask whether genetic counseling is appropriate

Care is multidisciplinary and personal

There is currently no cure or proven disease-modifying treatment. Care focuses on symptoms, safety, function, comfort, and the priorities of the person and family.

01

Movement

A movement-disorders neurologist may consider dopaminergic therapy and physical, occupational, and speech therapy. Responses vary.

02

Breathing

Pulmonology and sleep specialists can monitor for nocturnal hypoventilation and discuss non-invasive or other ventilatory support when appropriate.

03

Mood and thinking

Depression and suicidal thinking require active screening and treatment. Psychiatry, psychology, counseling, and caregiver support may all help.

04

Nutrition and swallowing

Dietitians and speech-language pathologists can support calorie needs, swallowing safety, communication, and decisions about assisted nutrition.

Important: Medication and ventilation decisions must be individualized. GeneReviews advises avoiding respiratory depressants such as alcohol, narcotics, and benzodiazepines unless a treating clinician has specifically assessed their use.

Landmark and current publications

A curated starting point for families, clinicians, and researchers. Links open the publisher or PubMed record.

Movement Disorders Clinical Practice

Perry Disease: Expanding the Genetic Basis

Expanded the known genetic region through a new pathogenic DCTN1 variant and clinicopathologic evidence.
Open article

Parkinsonism & Related Disorders

L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome

Showed that some people can have a marked, sustained response to L-Dopa and characteristic dystonia.
Open article

European Journal of Neurology

Clinical, pathological and genetic characteristics of Perry disease

A worldwide review with practical observations on symptoms, pathology, genetics, and management.
Open article

Journal of Movement Disorders

Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria

Explains the modern disease concept and the international clinical diagnostic framework.
Open article

Journal of Neurology, Neurosurgery & Psychiatry

Establishing diagnostic criteria for Perry syndrome

Established consensus criteria using 87 published patients from 20 families.
Open article

Nature Genetics

DCTN1 mutations in Perry syndrome

The landmark discovery linking disease-segregating DCTN1 variants to Perry syndrome.
Open article
Search all Perry syndrome publications

Learn from experts and clinical cases

These educational resources contain medical discussion and, in the clinical videos, real symptoms. Viewer discretion is advised.

The lives behind the literature

Because patient stories deserve consent and care, we do not invent testimonials. These anonymized summaries come from peer-reviewed case reports; first-person stories can be added only with a family’s permission.

After acute respiratory failure and diagnosis, respiratory intervention helped a woman remain highly independent at the published follow-up.

ColombiaRespiratory support and independence

A man initially benefited from BiPAP and continued part-time work and recreational cycling until late in his illness.

New ZealandWork, activity, and breathing support

Two close relatives with the same DCTN1 variant had very different movement symptoms and respiratory courses—showing why monitoring must be individualized.

United KingdomOne family, different disease courses

Clinicians and centers with published expertise

These contacts are drawn from peer-reviewed Perry syndrome work and current institutional profiles. Contact each center to ask about referrals, geography, telehealth, costs, and availability.

Published Perry syndrome expertise

Zbigniew K. Wszolek, MD

Mayo Clinic

Jacksonville, Florida · United States

Mayo Clinic neurologist, GeneReviews coauthor, and co-discoverer of the DCTN1 variants that cause Perry syndrome.

Contact or profile
Published Perry syndrome expertise

Jarosław Dulski, MD, PhD

Medical University of Gdańsk

Gdańsk · Poland

Neurologist and GeneReviews coauthor with extensive clinical and research publications on Perry syndrome.

Contact or profile
Published Perry syndrome expertise

Sonia Catalina Cerquera Cleves, MD

Hospital Universitario San Ignacio

Bogotá · Colombia

Neurologist at Hospital Universitario San Ignacio and coauthor of international Perry syndrome case and review studies.

Contact or profile
Published Perry syndrome expertise

Department of Neurology

Fukuoka University Hospital

Fukuoka · Japan

A neurology department with a Parkinson’s clinic; its researchers led work on international Perry disease diagnostic criteria.

Contact or profile

This is an educational referral aid, not an endorsement or guarantee that a clinician is accepting patients. A local movement-disorders neurologist, genetic counselor, sleep specialist, or pulmonologist can also coordinate with an experienced center.

Start with the essentials

01Is Perry syndrome the same as Parkinson’s disease?

No. It can cause parkinsonism, but it is a distinct inherited neurodegenerative condition linked to DCTN1 and has important respiratory, mood, and weight features.

02Can someone have it without a known family history?

Yes. Family history can be incomplete or unclear, and a new DCTN1 variant can occur. A genetics professional should interpret individual risk.

03Is genetic testing enough on its own?

A pathogenic DCTN1 result is central, but results must be interpreted in the context of symptoms and family history. Some DCTN1 variants cause other neurologic conditions, and uncertain variants do not confirm a diagnosis.

04Why is breathing monitoring so important?

Central hypoventilation can begin during sleep and may not be obvious to the person affected. Early respiratory assessment and follow-up can guide supportive treatment.

05Is there a cure?

There is no cure at present. Symptom-focused care and respiratory support can improve quality of life and may extend survival; research is continuing.

No family should navigate this alone.

Reach the foundation for support, research collaboration, story submissions, or help finding an appropriate clinical starting point.

If you or someone you know may act on suicidal thoughts, contact local emergency services or a crisis line now. In the U.S. and Canada, call or text 988.